A multiscale simulation framework for the manufacturing facility and supply chain of autologous cell therapies-Reference-Cited by-同舟云学术

A multiscale simulation framework for the manufacturing facility and supply chain of autologous cell therapies

Published:2019-10 Issue:10 Volume:21 Page:1081-1093
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Wang Kan,Liu Yi,Li Junxuan^ORCID,Wang Ben,Bishop Reid^ORCID,White Chip,Das Amritava,Levine Aaron D.,Ho Linda,Levine Bruce L.,Fesnak Andrew D.

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference25 articles.

1. Adoptive cell transfer as personalized immunotherapy for human cancer;Rosenberg;Science,2015

2. CAR T cell immunotherapy for human cancer;June;Science,2018

3. Gene Therapy in a Patient with Sickle Cell Disease;Ribeil;N Engl J Med,2017

4. Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia;Thompson;N Engl J Med,2018

5. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease;Ellebrecht;Science,2016

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interfacing data science with cell therapy manufacturing: where we are and where we need to be;Cytotherapy;2024-09

2. Development of a robotic cluster for automated and scalable cell therapy manufacturing;Cytotherapy;2024-09

3. Advancing autologous CAR T-cell therapy through real-time patient health data integration: a simulation-based approach;Cytotherapy;2024-05

4. The Science of CAR ‐T Cell Technology;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

5. Development of a robotic cluster for automated and scalable cell therapy manufacturing;2023-12-23